JP2009102262A - 神経変性疾患治療薬 - Google Patents
神経変性疾患治療薬 Download PDFInfo
- Publication number
- JP2009102262A JP2009102262A JP2007275790A JP2007275790A JP2009102262A JP 2009102262 A JP2009102262 A JP 2009102262A JP 2007275790 A JP2007275790 A JP 2007275790A JP 2007275790 A JP2007275790 A JP 2007275790A JP 2009102262 A JP2009102262 A JP 2009102262A
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- disease
- compound
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
酸化ストレスによる神経細胞障害を抑制し、安全な神経変性疾患治療薬を提供する。
【解決手段】
一般式
【化1】
(式中、R1は炭素数4〜8のアルキル基、R2は水素原子、炭素数2〜6のアルキルカルボニル基または炭素数2〜6のアルコキシカルボニル基を示す。)で表される化合物またはそのシクロデキストリン包接体からなるハイドロキノン誘導体を有効成分として含むことを特徴とする神経変性疾患治療薬である。
【選択図】なし
Description
(式中、R1は炭素数4〜8のアルキル基、R2は水素原子、炭素数2〜6のアルキルカルボニル基または炭素数2〜6のアルコキシカルボニル基を示す。)
(式中、R1は炭素数4〜8のアルキル基、R2は水素原子、炭素数2〜6のアルキルカルボニル基または炭素数2〜6のアルコキシカルボニル基を示す。)で表される化合物またはそのシクロデキストリン包接体からなるハイドロキノン誘導体を有効成分として含むことを特徴とする神経変性疾患治療薬を提供するものである。
前述の一般式(1)で示されるハイドロキノン誘導体のうち、2,3,5−トリメチルハイドロキノン−1−ヘキシルエーテル(化合物1)について、過酸化脂質による神経細胞に対する毒性の抑制作用をビタミンEとの比較の下に検討した。ヒト神経芽細胞種由来SH−SY5Y細胞およびラット副腎髄質褐色細胞種で神経細胞の培養モデルであるPC12細胞を常法に従って培養した。培地はDulbecco‘s Eagle Medium(DMEM)にFCS(牛胎児血清)を添加した培地を基本に、NaHCO3 (3.7g/L);Penicillin G(100U/mL);Streptomycin(100mg/ml)を添加したものを用い、24穴マイクロプレートを使用し、SH−SY5Y細胞は6×104個、PC12細胞は4×104個を接種し、CO2インキュベータ内で37℃ にて培養した。48時間後に化合物1またはビタミンEを添加した。さらにその約30分後に、リノール酸ヒドロペルオキシドをSH−SY5Y細胞に対しては70μM、PC12細胞に対しては35μM添加し、約20時間培養後に生存細胞を測定した。
保護率(%)={1−(100−被験物質添加群の生存率)÷(100−被験物質無添加群の生存率)}×100
る結果を[表2]に示す。
Claims (2)
- (A)一般式
- 化1で表される化合物が2,3,5−トリメチルハイドロキノン−1−ヘキシルエーテルまたは2,3,5−トリメチルハイドロキノン−1−ヘキシルエーテル 4−アセテートである請求項1に記載の神経変性疾患治療薬。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007275790A JP5198827B2 (ja) | 2007-10-23 | 2007-10-23 | 神経変性疾患治療薬 |
KR1020080050918A KR20090041304A (ko) | 2007-10-23 | 2008-05-30 | 신경 변성 질환 치료약 |
US12/230,667 US20090105339A1 (en) | 2007-10-23 | 2008-09-03 | Curative drug for neurodegenerative diseases |
ES08253402T ES2400451T3 (es) | 2007-10-23 | 2008-10-21 | Fármaco curativo para enfermedades neurodegenerativas |
EP08253402A EP2052719B1 (en) | 2007-10-23 | 2008-10-21 | Curative drug for neurodegenerative diseases |
US12/659,070 US20100160432A1 (en) | 2007-10-23 | 2010-02-24 | Curative drug for neurodegenerative diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007275790A JP5198827B2 (ja) | 2007-10-23 | 2007-10-23 | 神経変性疾患治療薬 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009102262A true JP2009102262A (ja) | 2009-05-14 |
JP5198827B2 JP5198827B2 (ja) | 2013-05-15 |
Family
ID=40227900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007275790A Active JP5198827B2 (ja) | 2007-10-23 | 2007-10-23 | 神経変性疾患治療薬 |
Country Status (5)
Country | Link |
---|---|
US (2) | US20090105339A1 (ja) |
EP (1) | EP2052719B1 (ja) |
JP (1) | JP5198827B2 (ja) |
KR (1) | KR20090041304A (ja) |
ES (1) | ES2400451T3 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170117174A (ko) | 2015-04-23 | 2017-10-20 | 니폰 하이폭스 라보레토리즈 인코포레이티드 | 만성 호흡기 질환 치료제 및 심장의 섬유화 억제 조성물 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6392783B2 (ja) * | 2013-12-20 | 2018-09-19 | 株式会社日本ハイポックス | 糖尿病性腎症の予防又は治療剤 |
LU100797B1 (en) * | 2018-05-15 | 2019-11-15 | Univ Luxembourg | 2-hydroxypropyl-beta-cyclodextrin for use in a method of treatment of a parkinsonian condition |
KR102013574B1 (ko) * | 2018-10-25 | 2019-08-23 | 주식회사 바이오톡스텍 | 하이드로퀴논 유도체를 포함하는 비만 또는 비알콜성 지방간염의 예방 또는 치료용 약학 조성물 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05301836A (ja) * | 1991-03-28 | 1993-11-16 | Nippon High Potsukusu:Kk | 新規ハイドロキノン誘導体 |
JPH08193026A (ja) * | 1995-01-12 | 1996-07-30 | Teijin Ltd | アミロイドβ蛋白凝集・沈着阻害剤 |
JP2004352661A (ja) * | 2003-05-29 | 2004-12-16 | Nippon Hypox Lab Inc | 難治性炎症性疾患治療剤 |
JP2005263734A (ja) * | 2004-03-19 | 2005-09-29 | Kagawa Univ | 希少糖の神経細胞における保護作用を利用する予防薬、治療薬、特定保健用食品 |
WO2005115375A1 (en) * | 2004-05-25 | 2005-12-08 | Othera Pharmaceuticals, Inc. | Oculoselective drugs and prodrugs |
WO2006014033A1 (en) * | 2004-07-31 | 2006-02-09 | Brainguard Co., Ltd. | Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2300543A1 (de) * | 1973-01-08 | 1974-07-11 | Basf Ag 6700 Ludwigshafen | Neue derivate des trimethylphenols und verfahren zu ihrer herstellung |
JPH07110812B2 (ja) | 1990-12-11 | 1995-11-29 | 財団法人喫煙科学研究財団 | 神経成長因子生合成促進剤 |
JPH06100441A (ja) | 1992-09-22 | 1994-04-12 | Nippon High Potsukusu:Kk | ハイドロキノン誘導体含有発ガン阻止剤 |
US5416242A (en) * | 1992-09-25 | 1995-05-16 | Nippon Hypox Laboratories Incorporated | Hydroquinone derivative |
JPH0867627A (ja) | 1994-08-31 | 1996-03-12 | Nippon High Potsukusu:Kk | 肝疾患治療用組成物 |
US5874468A (en) * | 1996-12-26 | 1999-02-23 | Yissum | Brain targeted low molecular weight hydrophobic antioxidant compounds |
JP4749562B2 (ja) | 2001-02-16 | 2011-08-17 | 株式会社日本ハイポックス | ハイドロキノン誘導体および動脈硬化治療用組成物 |
-
2007
- 2007-10-23 JP JP2007275790A patent/JP5198827B2/ja active Active
-
2008
- 2008-05-30 KR KR1020080050918A patent/KR20090041304A/ko not_active Application Discontinuation
- 2008-09-03 US US12/230,667 patent/US20090105339A1/en not_active Abandoned
- 2008-10-21 EP EP08253402A patent/EP2052719B1/en not_active Not-in-force
- 2008-10-21 ES ES08253402T patent/ES2400451T3/es active Active
-
2010
- 2010-02-24 US US12/659,070 patent/US20100160432A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05301836A (ja) * | 1991-03-28 | 1993-11-16 | Nippon High Potsukusu:Kk | 新規ハイドロキノン誘導体 |
JPH08193026A (ja) * | 1995-01-12 | 1996-07-30 | Teijin Ltd | アミロイドβ蛋白凝集・沈着阻害剤 |
JP2004352661A (ja) * | 2003-05-29 | 2004-12-16 | Nippon Hypox Lab Inc | 難治性炎症性疾患治療剤 |
JP2005263734A (ja) * | 2004-03-19 | 2005-09-29 | Kagawa Univ | 希少糖の神経細胞における保護作用を利用する予防薬、治療薬、特定保健用食品 |
WO2005115375A1 (en) * | 2004-05-25 | 2005-12-08 | Othera Pharmaceuticals, Inc. | Oculoselective drugs and prodrugs |
WO2006014033A1 (en) * | 2004-07-31 | 2006-02-09 | Brainguard Co., Ltd. | Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
Non-Patent Citations (1)
Title |
---|
JPN6012049654; Arch.Toxicol. Vol.79, 2005, p.531-541 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170117174A (ko) | 2015-04-23 | 2017-10-20 | 니폰 하이폭스 라보레토리즈 인코포레이티드 | 만성 호흡기 질환 치료제 및 심장의 섬유화 억제 조성물 |
KR20190006102A (ko) | 2015-04-23 | 2019-01-16 | 니폰 하이폭스 라보레토리즈 인코포레이티드 | 심장의 섬유화 억제 조성물 |
Also Published As
Publication number | Publication date |
---|---|
US20090105339A1 (en) | 2009-04-23 |
EP2052719A8 (en) | 2009-07-01 |
US20100160432A1 (en) | 2010-06-24 |
EP2052719B1 (en) | 2013-01-16 |
KR20090041304A (ko) | 2009-04-28 |
ES2400451T3 (es) | 2013-04-10 |
EP2052719A1 (en) | 2009-04-29 |
JP5198827B2 (ja) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020200420B2 (en) | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | |
JP6462045B2 (ja) | スルフォラファンの単離及び精製 | |
FR2753098A1 (fr) | Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene | |
JP5198827B2 (ja) | 神経変性疾患治療薬 | |
JP5804432B2 (ja) | ガルシノール、シクロデキストリンの複合体およびその方法 | |
US10945975B2 (en) | Delaying latency to seizure by combinations of ketone supplements | |
EP4226919A1 (en) | Ferroptosis inhibitor | |
JP2017534687A (ja) | 配合剤 | |
JP5919208B2 (ja) | 脳保護剤 | |
US20070066681A1 (en) | Pharmaceutical composition for treating fatty liver or hepatic disease | |
KR20090109055A (ko) | 간섬유화 억제제 | |
JP4382354B2 (ja) | 1−ブタン酸誘導体およびその使用 | |
EP2638902B1 (en) | Antimalarial drug comprising alaremycin or derivative thereof as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100527 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120925 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20121126 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130108 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130207 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160215 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5198827 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |